Global Payments Gains on Hookup with Banamex
Global Payments Inc. (NYSE: GPN), a leading worldwide provider of payment technology and software solutions, and Banco Nacional de México, S.A., member of the Banamex Financial Group, one of the top banks in Mexico with more than 141 years of history, today announced the multi-year renewal and expansion of their strategic alliance, reinforcing their commitment to bringing best-in-class commerce solutions to the acquiring and banking services market in Mexico.Global Payments partners with Banamex via its EVO Payments business, which processes nearly 900M transactions across more than 250,000 installed point-of-sale (POS) systems in Mexico.Extending the strategic alliance enables both companies to serve the full spectrum of merchants, from small and medium-sized businesses to enterprises, including both digital native and brick-and-mortar establishments. Through the strategic alliance, Global Payments provides leading integrated and embedded payment solutions alongside Banamex´s banking services offerings.“Our strategic alliance with Banamex has been an outstanding success story and we are pleased to continue serving the needs of merchants across Mexico with our valued partner,” said one company official. “Together, we will continue driving innovation forward so that businesses have the full range of leading commerce solutions they need to compete and win while delivering exceptional experiences for their customers.”GPN shares picks up 41 cents early Thursday to $83.07.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


